New York, N.Y. (September 30, 2013) – Autism Speaks, the world’s leading autism science and advocacy organization, has named physician-scientist Paul Wang to the position of senior vice president and head of medical research. He will be responsible for innovating Autism Speaks’ medical research portfolio with a specific focus innovating clinical trial capabilities.
“We are incredibly excited to have Paul joining our science team at Autism Speaks,” said Rob Ring, Chief Science Officer. “Paul brings a strong and relevant background at a time when our science mission is working harder than ever to put science to work for our families.”
Dr. Wang joins Autism Speaks from Seaside Therapeutics, where he served as vice president of clinical and medical affairs, and oversaw the company’s groundbreaking arbaclofen programs in autism and fragile X.
“I'm very excited to be joining the team at Autism Speaks, to exploit the advances and resources that Autism Speaks has already brought to the table, and to help make a difference for the children and families affected by ASD,” said Paul Wang, M.D., Senior Vice-President and Head of Medical Research.
Prior to joining Seaside Therapeutics, Dr. Wang was senior director, clinical development at Pfizer Global Research and Development from 2002-2008, where he helped lead medicines development programs for neurobehavioral disorders, including bipolar, ADHD and epilepsy.
Dr. Wang graduated from Harvard College with a bachelor of arts in biomedical sciences and received his medical degree from the Yale University School of Medicine. He completed a residency and chief residency in pediatrics at the University of Michigan, a research fellowship at the Salk Institute and a clinical fellowship at Children’s Hospital of Philadelphia (CHOP). During his time on the faculty of CHOP, Dr. Wang provided diagnostic and ongoing clinical care for hundreds of special needs children, including many with ASD. He has held leadership positions in many professional societies, including the American Academy of Pediatrics, American Board of Pediatrics and the Society for Developmental-Behavioral Pediatrics.
“Dr. Wang’s history as a developmental-behavioral pediatrician brings years of experience understanding and identifying treatments for children with developmental disabilities to Autism Speaks,” said Liz Feld, President of Autism Speaks.
Autism is a general term used to describe a group of complex developmental brain disorders – autism spectrum disorders – caused by a combination of genes and environmental influences. These disorders are characterized, in varying degrees, by communication difficulties, social and behavioral challenges, as well as repetitive behaviors. An estimated one in 88 children in the U.S. is on the autism spectrum – a 78 percent increase in six years that is only partly explained by improved diagnosis.
About Autism Speaks
Autism Speaks is the world’s leading autism science and advocacy organization. It is dedicated to funding research into the causes, prevention, treatments and a cure for autism; increasing awareness of autism spectrum disorders; and advocating for the needs of individuals with autism and their families. Autism Speaks was founded in February 2005 by Suzanne and Bob Wright, the grandparents of a child with autism. Mr. Wright is the former vice chairman of General Electric and chief executive officer of NBC and NBC Universal. Since its inception, Autism Speaks has committed nearly $200 million to research and developing innovative resources for families. Each year Walk Now for Autism Speaks events are held in more than 100 cities across North America. On the global front, Autism Speaks has established partnerships in more than 40 countries on five continents to foster international research, services and awareness. To learn more about Autism Speaks, please visit AutismSpeaks.org.